| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2017-08-09 | Spark Therapeutics (USA - PA) | $380.4 million | private placement | Private placement | ||
| 2017-07-28 | Iteos Therapeutics (Belgium) | € 7.5 million | grant | Walloon Region (Belgium) | Cancer - Oncology | Grant |
| 2017-07-26 | Quantum Genomics (France) | € 8.2 Million | capital increase | Cardiovascular diseases | Capital increase | |
| 2017-07-25 | Antabio (France) | up to $8.9 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | Debiopharm (Switzerland) | up to $ 4 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | Achaogen (USA - CA) | up to $ 11.5 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | Bugworks Research Inidia (India) | up to $ 6.2 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | Eligochem (UK) | up to $ 4.8 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | Iterum Therapeutics (Ireland) | up to $ 1.5 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-25 | VenatoRx Pharmaceuticals (USA - PA) | up to $ 9.4 million | grant | Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) | Infectious diseases | Grant |
| 2017-07-19 | Ose Immunotherapeutics (France) | €9.2 million | grant | Bpifrance (France) | Cancer - Oncology | Grant |
| 2017-07-19 | Akcea Therapeutics (USA - MA) | $193.8 million | IPO - private placement | Cardiovascular diseases - Metabolic diseases - Rare diseases | IPO | |
| 2017-07-18 | Eurofins Scientific (Luxembourg) | € 65 million | fundraising | Technology - Services | Fundraising | |
| 2017-07-07 | Biophytis (France) | € 18,7 million | capital increase - private placement | Bracknor Investment Group (Dubai) | Ageing diseases - Muscle disorders - Ophtalmological diseases | Capital increase |
| 2017-07-06 | Evotec (Germany) | grant | Hamburgische Investitions- und Förderbank (IFB Hamburg) (Germany) | Cancer - Oncology | Grant | |
| 2017-07-06 | Zealand Pharma (Denmark) | capital increase | Capital increase | |||
| 2017-07-05 | Anaeropharma Science (Japan) | $13.2 million | financing round | Novartis (Switzerland) Shinsei Corporate Investment (Japan) Seventure Partners (France) Innovation Network Corporation of Japan (Japan) Mitsubishi UFJ Capital (Japan) | Cancer - Oncology - Cardiovascular diseases | Financing round |
| 2017-06-29 | Melinta Therapeutics (USA - CT) | $ 90 million | loan | Oberland Capital (USA - NY) | Infectious diseases | Loan |
| 2017-06-27 | Daytwo (Israel) | $12 million | series A financing round | Seventure Partners (France), J&J (USA - NJ) historical investors | Series A financing round | |
| 2017-06-20 | iOnctura (Switzerland) | financing round | Merck Ventures (Germany) | Cancer - Oncology | Financing round |
